FDA Releases Final Guidance for Cell, Gene Therapy Standards
FDA issues final guidance to manufacturers of cellular and gene therapy products regarding science- and risk-based plans to meet potency standards.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed